Search filters

List of works by Arnold G Vulto

A health economic guide to market access of biosimilars

scientific article published on 18 November 2020

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

scientific article

An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

scientific article published on 01 January 2020

Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure

scientific article published on 30 March 2020

Biosimilars in Belgium: a proposal for a more competitive market

scientific article published on 13 May 2020

Comparative evaluation of three chromogenic agars for detection and rapid identification of aerobic Gram-negative bacteria in the normal intestinal microflora ⬇️

scientific article published on September 1, 2003

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.

scientific article

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2-Biosimilar and Originator Etanercept in the Outpatient Setting.

scientific article

Economic evaluation of biosimilars for reimbursement purposes - what, when, how?

scientific article published on 15 March 2020

European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption

scientific article published on 03 November 2020

European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice

scientific article published on 15 October 2020

Guidelines for the practical stability studies of anticancer drugs: A European consensus conference ⬇️

scientific article published on August 3, 2011

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

scientific article published on 01 April 2020

In vitro susceptibility to antimicrobial drugs of 62 Salmonella strains isolated from horses in The Netherlands ⬇️

scientific article published on June 1, 1995

Interchangeability, immunogenicity and biosimilars ⬇️

scientific article published on 01 December 2012

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

scientific article published on 21 October 2020

NosocomialMycobacteriumbovis–Bacille Calmette‐Guérin Infections Due to Contamination of Chemotherapeutics: Case Finding and Route of Transmission ⬇️

scientific article published on October 15, 2003

Policies for biosimilar uptake in Europe: An overview.

scientific article published on 28 December 2017

Risk management of biosimilars in oncology: each medicine is a work in progress ⬇️

scientific article published on January 25, 2012

Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review

scientific article published on 17 November 2020

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape

scientific article

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

scientific article published on 01 July 2019

The impact of reference-pricing systems in Europe: a literature review and case studies ⬇️

scientific article published on December 1, 2011

glycyrrhizin as a potential treatment for chronic hepatitis C ⬇️

scientific article published on March 1, 1998

Paulina is supported by:

About Paulina

Help